NCT03847727 2020-01-18
Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia
Pirogov Russian National Research Medical University
Unknown
Pirogov Russian National Research Medical University
Northwestern University